DOCSLIB.ORG

Cocaine Use in America: Epidemiologic and Clinical Perspectives

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cocaine Use in America: Epidemiologic and Clinical Perspectives Cocaine Use in America: Epidemiologic and Clinical Perspectives DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration Cocaine Use in America: Epidemiologic and Clinical Perspectives Editors: Nicholas J. Kozel, M.S. Edgar H. Adams, M.S. Division of Epidemiology and Statistical Analysis National Institute on Drug Abuse NIDA Research Monograph 61 1985 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse 5600 Fishers Lane Rockville, Maryland 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC. 20402 NIDA Research Monographs are prepared by the research divisions of the National Institute on Drug Abuse and published by its Office of Science. The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. Its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. SIDNEY COHEN, M.D. Temple University School of Medicine Los Angeles, California Philadelphia, Pennsylvania SYDNEY ARCHER, Ph.D. MARY L. JACOBSON Rensselaer Polytechnic lnstitute National Federation of Parents for Troy, New York Drug-Free Youth RICHARD E. BELLEVILLE, Ph.D. Omaha, Nebraska NB Associates, Health Sciences Rockville, Maryland REESE T. JONES, M.D. KARST J. BESTEMAN Langley Porter Neuropsychiatric lnstitute Alcohol and Drug Problems Association San Francisco, California of North America Washington, D.C. DENISE KANDEL, Ph.D. GILBERT J. BOTVIN, Ph.D. College of Physicians and Surgeons of Cornell University Medical College Columbia University New York, New York New York, New York JOSEPH V. BRADY, Ph.D. The Johns Hopkins University School of HERBERT KLEBER, M.D. Medicine Yale University School of Medicine Baltimore, Maryland New Haven, Connechicut THEODORE J. CICERO, Ph.D. Washington University School of RICHARD RUSSO Medicine New Jersey State Department of Health St. Louis, Missouri Trenton, New Jersey NIDA Research Monograph Series CHARLES R. SCHUSTER, Ph.D. Drector, NIDA JEAN PAUL SMITH, Ph.D. Acting Associate Director for Science, NIDA Acting Editor Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857 Cocaine Use in America: Epidemiologic and Clinical Perspectives ACKNOWLEDGMENT This monograph is based upon papers presented at a technical review of patterns of cocaine use in the United States which took place on July 11-13, 1984, at Bethesda, Maryland. The conference was sponsored by the Division of Epidemiology and Statistical Analysis, National Institute on Drug Abuse. COPYRIGHT STATUS All material in this volume except quoted passages from copy- righted sources is in the public domain and may be used or repro- duced without permission from the Institute or the authors. Citation of the source is appreciated. Opinions expressed in this volume are those of the authors and do not necessarily reflect the opinions or official policy of the National Institute on Drug Abuse or any other part of the U.S. Department of Health and Human Services. The U.S. Government does not endorse or favor any specific commercial product or commodity. Trade or proprietary names appearing in this publication are used only because they are con- sidered essential in the context of the studies reported herein. DHHS Publication No. (ADM)90-1414 Alcohol, Drug Abuse, and Mental Health Administration Printed 1985, Reprinted 1987, 1990 NIDA Research Monographs are indexed in the Index Medicus. They are selectively included in the coverage of American Statistics Index, Biosciences Information Service, Chemical Abstracts, Current Contents, Psychological Abstracts, and Psychopharmacology Abstracts. iv Foreword Over the past 10 years, cocaine, which has been characterized as powerfully addictive, has evolved from a relatively minor problem into a major public health threat. In the early 197Os, evidence on the reinforcing potential of cocaine suggested that if the use of the drug became widespread major social and public health problems could ensue. Fortunately, NIDA had epidemiologic surveys and surveillance systems in place which enabled it to monitor the prevalence of drug use, cocaine- related emergency room cases, and treatment admissions. These efforts have documented dramatic increases in the use of cocaine in the general adult and high school populations of the United States. As the use of cocaine increased, parallel increases in emergency room visits, overdose deaths, and clinical problems reflected by increased treatment admissions were noted. Although the prevalence of cocaine use in the general population appears to have leveled off since 1979, the adverse consequences have con- tinued to increase dramatically. Several explanations, including increased combination drug use, a shift to more dangerous routes of administration, and the lag time from first use to entry into treatment have been offered to explain this phenomenon. There is evidence to suggest that each of these explanations may in fact contribute to the increased negative consequences associated with cocaine. Yet, as much as we know about the epidemiology of cocaine use, many questions remain. It is unknown, for example, whether the increasing number of freebase users seen by clinicians reflects an increase in the numbers of people smoking freebase or a reflection of the increased risk of this route of administra- tion. While our surveys have given us good estimates of the number of people who have used cocaine, we still need an estimate of the proportion of the using population who have experienced problems due to their drug use. In contrast, clinicians often see the problem users but may not collect sufficient drug histories so that risk may be assessed and have no contact with users who are not experiencing problems. The dialogue between epidemiologists and clinicians at the technical review on which this monograph is based increased the awareness of these issues and the benefits to be derived from increased interaction between epidemiologists and clinicians. One result of the technical review was the inclusion of a problem measurement section in the 1985 National Household Survey on Drug Use. Another is the publication of this monograph which represents an important contribution to our understanding of cocaine use and abuse. Charles R. Schuster, Ph.D. Director National Institute on Drug Abuse V Contents Foreword Charles R. Schuster . V Cocaine Use in America: Introduction and Overview Edgar H. Adams and Nicholas J. Kozel . 1 Cocaine Use in the United States: In a Blizzard or Just Being Snowed? Richard R. Clayton . 8 A Decade of Trends in Cocaine Use in the Household Popula- tion Herbert I. Abelson and Judith Droitcour Miller . 35 Cocaine Use Among American Adolescents and Young Adults Patrick M. O'Malley, Lloyd D. Johnston and Jerald G. Bachman . 50 Cocaine Use in Young Adulthood: Patterns of Use and Psycho- social Correlates Denise B. Kandel, Debra Murphy and Daniel Karus . 76 Patterns and Consequences of Cocaine Use Dale D. Chitwood . 111 Cocaine Abuse: Neurochemistry, Phenomenology, and Treatment Mark S. Gold, Arnold M. Washton and Charles A. Oackis . 130 Reinforcement and Rapid Delivery Systems: Understanding Adverse Consequences of Cocaine Sidney Cohen . 151 Characteristics of Humans Volunteering for a Cocaine Research Project C. R. Schuster and M. W. Fischman . 158 Characteristics of Cocaine Abusers Presenting for Treatment Sidney H. Schnoll, Judy Karrigan, Sarah B. Kitchen, Amin Daghestani, and Thomas Hansen . 171 vii Cocaine Use in a Treatment Population: Patterns and Diagnostic Distinctions Frank H. Gawin and Herbert D. Kleber . 182 Cocaine: Treatment Perspectives Donald R. Wesson and David E. Smith . 193 New Patterns of Cocaine Use: Changing Doses and Routes Ronald K. Siegel ....................................... 204 Cocaine Use in America: Summary of Discussions and Recommendations Nicholas J. Kozel and Edgar H. Adams . 223 List of NIDA Research Monographs . 229 viii Cocaine Use in America: Introduction and Overview Edgar H. Adams and Nicholas J. Kozel In the mid-1970s, as the reinforcing potential of cocaine was being demonstrated in the laboratory, the prevalence of cocaine abuse in the general household population of the United States was increasing dramatically. The fourfold increase from 5.4 million in 1974 to 21.6 million in 1982 in the number of people who reported having tried cocaine at least once has been well docu- mented (Blanken et al. 1985; Adams and Durell 1984). Based on data from the National Household Survey on Drug Abuse (1974-1984), lifetime prevalence of cocaine use continued to increase into the early 1980s. The number of current users (used in the past 30 days), however, remained stable between 1979 and 1982. Recent reports of increasing emergency room cases associated with cocaine, increasing deaths, and rising treatment admissions for cocaine problems have heightened concern that the incidence (new use) of cocaine use may be increasing once again. On the other hand, it has been suggested that this increase in untoward effects of cocaine use Is the result of changing routes of administration and more intensive patterns of use, including the use of cocaine In combination with other drugs. It has been noted also that the median time from first use of
Load more

Recommended publications
  • Drug Use Sequencing and Kandel's Gateway Hypothesis John Reid Clemson University, [email protected]
    Clemson University TigerPrints All Theses Theses 8-2008 Drug Use Sequencing and Kandel's Gateway Hypothesis John Reid Clemson University, [email protected] Follow this and additional works at: https://tigerprints.clemson.edu/all_theses Part of the Sociology Commons Recommended Citation Reid, John, "Drug Use Sequencing and Kandel's Gateway Hypothesis" (2008). All Theses. 447. https://tigerprints.clemson.edu/all_theses/447 This Thesis is brought to you for free and open access by the Theses at TigerPrints. It has been accepted for inclusion in All Theses by an authorized administrator of TigerPrints. For more information, please contact [email protected]. DRUG USE SEQUENCING AND KANDEL'S GATEWAY HYPOTHESIS A Thesis Presented to the Graduate School of Clemson University In Partial Fulfillment of the Requirements for the Degree Master of Science Applied Sociology by John Matthew Reid August 2008 Accepted by: Dr. Brenda Vander Mey, Committee Chair Dr. Douglas Kinly Sturkie Dr. Margaret Tina Britz i ABSTRACT This thesis tests the hypothesis by Kandel (1975) that there is a specific sequence of drug use that users follow. Using the same scalogram analysis technique utilized by Kandel in her original Gateway Hypothesis study, a distinct sequence of use was discovered. This thesis is based on the National Survey on Drug Use and Health (2005). This study confirmed Kandel’s earlier findings in that this study determined that there is a sequence of drug use. The current study also confirms Kandel’s position that licit drugs precede the use of illicit drugs. This study’s findings differ from those of Kandel, however, in that tobacco and not alcohol was found to be the first drug of experimentation.
    [Show full text]
  • A Molecular Basis for Nicotine As a Gateway Drug
    The new england journal of medicine special article shattuck lecture A Molecular Basis for Nicotine as a Gateway Drug Eric R. Kandel, M.D., and Denise B. Kandel, Ph.D. From the Howard Hughes Medical Insti- n the historic occasion of the 122nd Shattuck Lecture and tute (E.R.K.), Kavli Institute for Brain Sci- the 200th anniversary of the New England Journal of Medicine, we chose to ad- ence (E.R.K.), and the Departments of Neuroscience (E.R.K.) and Psychiatry Odress a topic that is at once scientific and personally historic. In recent (E.R.K., D.B.K.), College of Physicians debates over legalizing marijuana, from all-out acceptance in Colorado to narrow and Surgeons, and Mailman School of decriminalization in Maryland, the scientific question of the role of marijuana as a Public Health (D.B.K.), Columbia Univer- sity, and the New York State Psychiatric gateway drug (i.e., a drug that lowers the threshold for addiction to other agents) Institute (D.B.K.) — all in New York. Ad- has loomed large. Both opponents and proponents of legalization have distorted dress reprint requests to Dr. E. Kandel at what science does and does not tell us — and both sides have overlooked the im- the Department of Neuroscience, Col- lege of Physicians and Surgeons, Colum- portance of nicotine as a gateway drug. bia University, 1051 Riverside Dr., Unit Epidemiologic studies have shown that nicotine use is a gateway to the use of 87, New York, NY 10032, or at erk5@ marijuana and cocaine in human populations.
    [Show full text]
  • 2016 and Over 4,000 Research Scientists, 168 Scientific Leaders and 60,000 Was Our Leader and Guiding Light, Providing Inspiration and Moti- Pression
    INVEST IN MENTAL HEALTH ANNUAL REPORT 2 0 1 6 Dear Brain & Behavior Research Foundation Supporters: From mental illness to mental health–30 years of achievements by tremendous impact on psychiatric research and treatment. Connie problems improves symptoms of some patients with refractory de- The Foundation is proud of our accomplishments in 2016 and over 4,000 research scientists, 168 scientific leaders and 60,000 was our leader and guiding light, providing inspiration and moti- pression. In a study of patients with treatment-resistant depression, we are excited to focus on the promising path of discovery. With donors. We are proud to present you with our 2016 annual report vation to all who ever had the honor and privilege of knowing and about two thirds had metabolic deficiencies that affect the brain’s your sustained commitment, we will accelerate the funding of our and invite you to invest in mental health. working with her. She will be dearly missed by us all. But her legacy ability to produce neurotransmitters. Dr. Pan’s research found Grants and continue to lead the field with breakthroughs that continues with each new scientist which we support and each new that patients’ depression symptoms declined significantly when improve the lives of those living with mental illness. Thank you for Since 1987, the Brain & Behavior Research Foundation has invest- discovery which improves people’s lives. their metabolic problems were treated. Some of the patients even continuing the journey with us. ed in the future. We support the innovative brain and behavior reached remission. The most common of the deficiencies observed research today which will lead to new treatments and eventual While we are proud of our accomplishments, there is still much in the participants was in levels of cerebral folate, which is treat- Sincerely, cures in the future.
    [Show full text]
  • Substance Abuse by Adolescents in 1977 with 499 French Adolescents
    In a country like Israel, which is deeply committed to the main sources of infection, among them active foci achievement of an expanded immunization program, the still present in the neighboring territories. effort to reach this objective should be weighed within the national program aimed at elimination of the diseases References .................................. controlled by mass immunization. Analysis of present achievements clearly shows that measles, together with 1. Swartz, T. A., and Klingberg, W.: Routine measles immu- poliomyelitis and rubella, deserves to be included among nization in Israel: A three-year clinical and serologic follow- up. In International conference on application of vaccines the first priorities of a program whose objective is elim- against viral, rickettsial, and bacterial diseases of man, ination of clinical disease. Washington, D.C., 14-18 December 1970. Pan American Health Organization, Washington, D.C., 1971, pp. Conclusions 265-268. 2. Centers for Disease Control: Measles Surveillance Report No. 11, 1977-1981. Atlanta, Ga., September 1982. A 17-year-old immunization program has created the 3. Health and Welfare Canada: Measles in Canada. Canada basis for elimination of measles in Israel, provided that Diseases Weekly Report 9-25: 29-101 (1983). (a) the control policy is adapted to the seroepidemiology 4. World Health Organization: Measles surveillance. Weekly of the infection, and (b) a concentrated logistic effort is Epidemiol Record 58: 85-86 (1983). mounted in the period preceding the next expected epi- 5. Hopkins, D. R., Hinman, A. R., Kaplan, J. E, and Lane, J. M.: The case for global measles eradication. Lancet 1: demic. Under this effort: 1936-1938, June 19, 1982.
    [Show full text]
  • DOCUMENT RESUME ED 222 832 CG 016 300 AUTHOR Lettieri, Dan
    DOCUMENT RESUME ED 222 832 CG 016 300 AUTHOR Lettieri, Dan J., Ed.; Ludford, Jacqueline P., Ed. TITLE Drug Abuse and the American Adolescent. NIDA Research Monograph 38. A RAUS Review Report. INSTITUTION National Inst. on Drug Abuse (DHHS), Rockville, Md. Div. of Research. REPORT NO DHHS-ADM-81-1166 PUB DATE 8 Sep 80 NOTE 140p.; Papers presented at the Research Analysis and Utilization System (RAUS) Review Conference on Drug Abuse and the American Adolescent (Rockville, MD, September 8, 1980). AVAILABLE FROMSuperintendent of Documents, U.S. Government Printing Office, Washington, DC 20402. PUB TYPE Collected Works - Conference Proceedings (021) Reference Materials - Bibliographies (131) Reports Research/Technical (143) EDRS PRICE MF01/PC06 Plus Postage. DESCRIPTCRS *Adolescents; Biomedicine; Cohort Analysis; *Delinquent Behavior; Drinking; *Drug Abuse; Individual Differences; Literature Reviews; Longitudinal Studies; *Peer Influence; Personality Traits; *Predictor Variables; Secondary Education; *Youth Problems IDENTIFIERS *Epidemiology ABSTRACT This report reviews five studiei-dealing with drug abuse and adolescence and presents an overview of the social changes which have contributed to the increased use of marijuana and other illicit drugs. The importance of the longitudinal study as a research tool is emphasized in describing the research projects that dealwith the epidemiology of drug use, personality and sociodemographic factors, peer influence, the relationship between delinquency and drug use, and its biomedical consequences. The report closes with an executive summary, discussion, and suggestions for further research. An annotated list of NIDA (National Institute of DrugAbuse) research monographs is included. (JAC) *********************************************************************** Reproductions supplied by EDRS are the best that can be made from the original document. *********************************************************************** Drug Abuse and the American Adolescent Editors: Dan J.
    [Show full text]
  • Is Cannabis a Gateway Drug? Key Findings and Literature Review
    U.S. Department of Justice Office of Justice Programs National Institute of Justice National Institute of Justice Is Cannabis a Gateway Drug? Key Findings and Literature Review Wm. Nel, MSc, Researcher Judy Wang, PhD, Researcher November 2018 A Report Prepared by the Federal Research Division, Library of Congress, Under an Interagency Agreement with the Office of the Director, National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. NCJ 252950 U.S. Department of Justice Office of Justice Programs 810 Seventh St. N.W. Washington, DC 20531 David B. Muhlhausen, Ph.D. Director, National Institute of Justice This and other publications and products of the National Institute of Justice can be found at: National Institute of Justice Strengthen Science • Advance Justice nij.ojp.gov Office of Justice Programs Building Solutions • Supporting Communities • Advancing Justice O J P.gov The National Institute of Justice is the research, development, and evaluation agency of the U.S. Department of Justice. NIJ’s mission is to advance scientific research, development, and evaluation to enhance the administration of justice and public safety. The National Institute of Justice is a component of the Office of Justice Programs, which also includes the Bureau of Justice Assistance; the Bureau of Justice Statistics; the Office for Victims of Crime; the Office of Juvenile Justice and Delinquency Prevention; and the Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering, and Tracking. Opinions or conclusions expressed in this paper are those of the authors and do not necessarily reflect the official position or policies of the U.S. Department of Justice.
    [Show full text]
  • 17Th European Society for Biomedical Research on Alcoholism Congress 21-24 September 2019, Lille – Invited Talks and Symposia Abstracts
    Directeur de la rédaction Pr François Paille Rédacteur en chef Pr Amine Benyamina Rédacteurs associés Dr Philippe Batel Dr Ivan Berlin Dr Laurent Karila Pr Michel Lejoyeux Pr Mickaël Naassila Rédactrice Sciences humaines Pr Myriam Tsikounas Rédactrice Sciences psychologiques Pr Isabelle Varescon-Pousson Comité de rédaction Pr Georges Brousse Pr Olivier Cottencin Dr Michel Craplet Pr Jean-Bernard Daeppen Dr Jean-Michel Delile Pr Maurice Dematteis Dr Claudine Gillet th Dr Geneviève Lafaye 17 European Society for Biomedical Research Pr Michel Reynaud Dr Alain Rigaud Dr Marc Valleur on Alcoholism Congress Directeur de la publication Pr Mickael Naassila 21-24 September 2019, Lille Comité scientifique Pr Jean Adès Pr Thomas F. Babor Pr Jean-Louis Balmès Pr Maurice Bazot Dr Mats Berglund Pr Jacques Besson Pr Jean-Pierre Blayac Pr Jonathan D. Chick Mme Marie Choquet Pr Philippe de Witte Pr Michel Escande Pr Claude Got Dr Antoni Gual Pr Momar Gueye Pr Roger Henrion Pr Denise Kandel Pr Michel Le Moal Pr Karl Mann Mme Véronique Nahoum-Grappe Dr José Maria Neves Cardoso Pr Philippe-Jean Parquet Pr Jean-Louis Pedinielli Pr Falvio Poldrugo Pr Bernard Roques Pr John A. Talbott Pr Jean-Luc Vénisse Pr Lars von Knorring Pr Jacques Weill Pr Jean-Jacques Yvorel ISSN 2554-4853 Trimestriel Société Française PRINCEPS Éditions SEPTEMBRE-DÉCEMBRE 2019 - Tome 41, n° 3-4 d’Alcoologie !BSTRACTS CONGRÈS Pr Mickael Naassila* * President 17th ESBRA Meeting 17th European Society for Biomedical Research on Alcoholism congress 21-24 September 2019, Lille – Invited talks and Symposia abstracts Invited talks forward, such as combining training with neurostimulation.
    [Show full text]
  • Cocaine Use in America: Epidemiologic and Clinical Perspectives
    DOCUMENT RESUME ED 268 463 CG 019 022 AUTHOR Kozel, Nicholas J., Ed.; Adams, Edgar H., Ed. TITLE Cocaine Use in America: Epidemiologic and Clinical Perspectives. National Institute on Drug Abuse (NIDA) Research Monograph Series 61. INSTITUTION National Inst. on Drug Abuse (DHHS/PHS), Rockville, Md. REPORT NO DHHS-ADM-85-1414 PUB DATE 85 NOTE 243p. AVAILABLE FROMSuperintendent of Documents, U.S. Government Printing Office, Washington, DC 20402. PUB TYPE Reports - Research/Technical (143) -- Collected Works General (020) EDRS PRICE MF01/PC10 Plus Postage. DESCRIPTORS *Adolescents; *Behavior Patterns; *Drug Abuse; *Illegal Drug Use; Individual Characteristics; *Trend Analysis; *Young Adults IDENTIFIERS *Cocaine ABSTRACT This monograph is based on papers presented at a technical review of patterns of cocaine use in the United States which was held in 1984. The foreword by Jerome H. Jaffe acknowledges that, over the past 10 years, cocaine has become a major public health threat in this country. Papers contained in this monograph include: (1) "Cocaine Use in America: Introduction and Overview" by Edgar H. Adams and Nicholas J. Kozel; (2) "Cocaine Use in the United States: In a Blizzard or Just Being Snowed?" by Richard R. Clayton; (3) "A Decade of Trends in Cocaine Use in the Household Population" by Herbert I. Abelson and Judith Droitcour Miller; (4) "Cocaine Use Among American Adolescents and Young Adults" by Patrick M. O'Malley, Lloyd D. Johnston, and Jerald G. Bachman; (5) "Cocaine Use in Young Adulthood: Patterns of Use and Psychosocial Correlates" by Denise B. Kandel, Debra Murphy, and Daniel Karus; (6) "Patterns and Consequences of Cocaine Use" by Dale D.
    [Show full text]
  • Preventing Adolescent Drug Abuse: Intervention Strategies, 47
    RESEARCH ANALYSIS and UTILIZATION SYSTEM Preventing Adolescent Drug Abuse: Intervention Strategies U. S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service • Alcohol, Drug Abuse, and Mental Health Administration Preventing Adolescent Drug Abuse Intervention Strategies Editors: Thomas J. Glynn, Ph.D. Carl G. Leukefeld, D.S.W. Jacqueline P. Ludford, M.S. National Institute on Drug Abuse NIDA Research Monograph 47 A RAUS Review Report DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse 5600 Fishers Lane Rockville, Maryland 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, D.C. 20402 NIDA Research Monographs are prepared by the research divtsrons of the National lnstitute on Drug Abuse and published by its Office of Science. The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. Its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph D. SIDNEY COHEN, M.D Temple University School of Medicine Los Angeles, California Philadelphia, Pennsylvania SYDNEY ARCHER, Ph.D. MARY L. JACOBSON Rensselaer Polytechnic lnstitute National Federation of Parents for Troy, New York Drug Free Youth Omaha, Nebraska RICHARD E. BELLEVILLE, Ph.D. NB Associates, Health Sciences Rockville, Maryland REESE T. JONES, M.D. KARST J. BESTEMAN Langley Porter Neuropsychiatric Institute Alcohol and Drug Problems Association San Francisco, California of North America Washington, D.C DENISE KANDEL, Ph.D.
    [Show full text]
  • NCI Cancer Prevention Fellowship Program
    DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE NATIONAL INSTITUTES OF HEALTH NATIONAL CANCER INSTITUTE 4TH JOINT MEETING OF THE BOARD OF SCIENTIFIC ADVISORS AND THE NATIONAL CANCER ADVISORY BOARD Summary of Meeting December 2, 2014 Building 31C, Conference Room 10 National Institutes of Health Bethesda, Maryland 4th Joint Meeting of the Board of Scientific Advisors and the National Cancer Advisory Board NATIONAL CANCER ADVISORY BOARD BETHESDA, MARYLAND Summary of Meeting December 2, 2014 The Board of Scientific Advisors (BSA) and the National Cancer Advisory Board (NCAB) convened for the 4th Joint Meeting on 2 December 2014, in Conference Room 10, C Wing, Building 31, National Institutes of Health (NIH), Bethesda, MD. The meeting was open to the public on Tuesday, 2 December 2014, from 8:30 a.m. to 12:30 p.m. and 1:15 p.m. to 4:55 p.m., and closed to the public from 12:30 p.m. to 1:15 p.m. The BSA Chair, Todd R. Golub, Chief Scientific Officer, The Broad Institute of Harvard University and Massachusetts Institute of Technology, and the NCAB Chair, Tyler Jacks, Director, Koch Institute for Integrative Cancer Research, David H. Koch Professor of Biology, Massachusetts Institute of Technology, presided during the open session. Dr. Jacks presided during the closed session. BSA Members NCAB Members Dr. Todd R. Golub (Chair) Dr. Tyler E. Jacks (Chair) Dr. Francis Ali-Osman (absent) Dr. David C. Christiani (absent) Dr. Kenneth C. Anderson Dr. Marcia R. Cruz-Correa (absent) Dr. Dafna Bar-Sagi Dr. Kevin J. Cullen Dr. Ethan M.
    [Show full text]
  • Table of Contents SPR
    Table of Contents SPR ABOUT THE ANNUAL MEETING and SPR Acknowledgements ......................................................................................................... 3 Welcome from the President ............................................................................................ 7 Board of Directors .......................................................................................................... 9 Welcome from the Program Planning Committee Chair ................................................... 13 Program Committees ...................................................................................................... 14 About SPR ..................................................................................................................... 20 SPR Awards .................................................................................................................... 21 Celebrating 10 Years of Prevention Science ........................................................................ 23 MEETING PROGRAM AND ACTIVITIES Preconference Workshops ................................................................................................. 25 Diversity Network Committee and DNC Meeting Activities .............................................. 35 ECPN and ECPN Meeting Activities ................................................................................ 39 Sloboda and Bukoski SPR Cup ......................................................................................... 42 Wednesday Highlights
    [Show full text]
  • Problems of Drug Dependence 1989: Proceedings of the 51St Annual
    National Institute on Drug Abuse MONOGRAPH SERIES Problems of Drug Dependence 1989 Proceedings of the 51st Annual Scientific Meeting The Committee on Problems of Drug Dependence, Inc. U S DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol, Drug Abuse, and Mental Health Administration Problems of Drug Dependence 1989 Proceedings of the 51st Annual Scientific Meeting The Committee on Problems of Drug Dependence, Inc. Editor: Louis S. Harris, Ph.D. NIDA Research Monograph 95 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICE Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse Off ice of Science 5600 Fishers Lane Rockville, MD 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 NIDA Research Monographs are prepared by the research divisions of the National Institute on Drug Abuse and published by its Office of Science. The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. Its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. MARY L. JACOBSON Temple University School of Medicine National Federation of Parents for Philadelphia, Pennsylvania Drug-free Youth Omaha, Nebraska SYDNEY ARCHER, Ph.D. Rensselaer Polytechnic Institute Troy, New York REESE T. JONES, M.D. Langley Porter Neuropsychiatric Institute RICHARD E. BELLEVILLE, Ph.D. San Francisco, California NB Associates, Health Sciences Rockville, Maryland DENISE KANDEL, Ph.D. KARST J. BESTEMAN College of Physicians and Surgeons of Alcohol and Drug Problems Association Columbia University of North America New York, New York Washington, D.C.
    [Show full text]